Overview of gene editing technology


Since 2000, we have established a reliable and efficient service platform for genetically engineered mice and we are committed to providing the best-in-class solutions for genetically engineered animal models. To achieve that, we have:


  • Dedicated project management team 

  • AI-driven automated design platform SmartEddi 

  • Team of highly experienced research staff


The following three types of genetic engineering technologies are used to generate genetically engineered mouse(GEM) models:



Comparison

es-cas-tg.png




Embryonic Stem Cell Targeting


 image.png

In murine embryonic stem cells, the exchange of an endogenous allele of a target gene for a mutated copy via homologous recombination allows the generation of  targeted ES cells with defined mutations. Genetically engineered ES cells remain pluripotent and are able to develop into germ cells in the chimeric animals, thereby ensuring the germline transmission and the creation of a genetically modified line. As of today, embryonic stem cells targetng remains the most classic and reliable genetic engineering technology for mouse models.


Currently, SMOC provides mouse ES cells with three types of genetic background: C57BL/6, 129/S6, B6;129.

These mouse ES cells can be used to generate the following types of mouse models:

  • Gene knockout

  • Conditional gene knockout

  • KO first

  • Gene knock-in

  • Point mutation

  • Conditional point mutation

  • Targeted gene overexpression

  • Humanization


SMOC will select the most appropriate technology for each project on a case-by-case basis, by taking project duration and technology risk into account. 

Workflow of mouse genetic engineering with ES cell targeting 

  • Design and generate homologous recombination vectors

  • Transfer the homologous recombination vectors into murine ES cells

  • Screen and validate the positive targeted ESC clones

  • Microinject positive ESC clones into mouse blastocysts

  • Transplant the injected mouse blastocysts into the uterus of pseudopregnant female mice

  • Generate and screen positive chimeric mice F0

  • Obtain F1 heterozygous mice by mating positive F0 with wild-type mice or FLP mice


CRISPR Gene Editing Technology


image.png


Advantages of CRISPR gene editing technology

  • Faster compared to the traditional method.

  • Not limited by the availability of mouse genetic strains

  • More cost efficient 


Workflow of mouse genetic engineering with CRISPR/Cas9 technology

  • Select target site and design sgRNA, design homologous recombination vector (optional)

  • Prepare sgRNA and Cas9 mRNA, generate homologous recombination vector (optional)

  • Microinject sgRNA and Cas9 mRNA (and homologous recombination vector (optional)) into mouse fertilized eggs

  • Transplant fertilized eggs into the oviducts of pseudopregnant female mice

  • Generate and screen positive chimeric mice F0

  • Obtain F1 heterozygous mice by mating positive F0 with wild-type mice


Random Transgenes

image.png

A pre-designed gene (or genes) are randomly integrated into the mouse genome through pronuclear microinjection to generate transgenic mice. PiggyBac transposon system usually improves the efficiency. 

Workflow of mouse genetic engineering via random transgenes 

  • Design and generate transgenic plasmid

  • Inject linearized transgenic plasmid into mouse fertilized eggs

  • Transplant fertilized eggs into the oviducts of pseudopregnant female mice

  • Generate and screen positive chimeric mice F0

Workflow of mouse genetic engineering via piggBac transposon system 

  • Design and generate PiggyBAC transposon plasmid

  • Inject transposon plasmid and PiggyBAC transposase into mouse fertilized eggs

  • Transplant fertilized eggs into the oviducts of pseudopregnant female mice

  • Generate and screen positive chimeric mice F0


Popular articles

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more
Shanghai Model Organisms Jinshan R&D Base officially put into operation

After the base is put into operation, SMOC’s capability to provide genetically modified rat/mouse models and technical services including gene function research and drug development will be greatly enhanced.

Learn more